A Prospective Study to Evaluate the Effect of Preoperative Topical Brimonidine Tartrate 0.2% (Allergan, Irvine, CA) on Intraocular Pressure (IOP) of Patients Undergoing Robot-assisted Laparoscopic Prostatectomy (RALP)
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Brimonidine (Primary)
- Indications Ocular hypertension
- Focus Therapeutic Use
- Acronyms IOPsTBURG
- 27 Jul 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Jul 2017.
- 27 Jul 2016 Status changed from not yet recruiting to recruiting.
- 13 Jul 2016 New trial record